KITLG and Miyoshi myopathy: DAZAP1 plays a critical role in regulating the activation of ERK signaling pathway via modulating AS of KITLG mRNA to increase the proliferation of MM cells, which provide mechanistic insights into DAZAP1 as a promising therapeutic target for MM (Figure 7).